Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six
Go back to Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six| (NASDAQ: WVE) | Delayed: 6.04 -0.13 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.17 | 52 Week High | $38.50 | |||
| Open | $6.18 | 52 Week Low | $8.95 | |||
| Day High | $6.31 | P/E | N/A | |||
| Day Low | $6.02 | EPS | $0.00 | |||
| Volume | 2,363,585 | |||||
| (NASDAQ: WVE) | Delayed: 6.04 -0.13 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.17 | 52 Week High | $38.50 | |||
| Open | $6.18 | 52 Week Low | $8.95 | |||
| Day High | $6.31 | P/E | N/A | |||
| Day Low | $6.02 | EPS | $0.00 | |||
| Volume | 2,363,585 | |||||

